SINGAPORE - Investments in start-ups have grown exponentially, with ventures in Singapore raising more than $14.7 billion in 2021.
It comes amid data which shows a significant increase in funding activities over the last five years as the Republic's innovation and start-up ecosystem continues to grow.
Enterprise Singapore (EnterpriseSG) on Wednesday said investments in start-ups grew by more than 45 per cent per annum between 2017 and 2021, with venture funding within the first half of 2022 alone reaching $8.18 billion.
Image: Data shows significant increase in funding activities over the last five years as Singapore's innovation and start-up ecosystem continues to grow. ST PHOTO: KUA CHEE SIONG
Why it matters: Do you have aspirations of working for the most valuable company in the world? With its $2.35 trillion market cap, Apple offers plenty of employee benefits, but getting on the payroll isn't easy. According to boss Tim Cook, there are four qualities Cupertino looks for in its potential hires.
A team of University of Arkansas physicists has successfully developed a circuit capable of capturing graphene's thermal motion and converting it into an electrical current.
What does it mean to democratize access to information and open channels to a global network of investors? Modern money is no longer buffered by fortress walls but in constant motion and actively seeking investment opportunities with doors wide open...if only you can find it. Entrepreneurs are no longer working out of makeshift garage spaces, but moving in sync with the new cadres of digital nomads, opening themselves up to broader exposure and more chance interactions than ever before. Decentralization is the buzzword on everyone's mind. Is it the key for those who will go on to master the Web3 revolution?
Carolyn Bertozzi, Morten Meldal and K. Barry Sharpless have been awarded the 2022 Nobel Prize in Chemistry for the development of click chemistry and bioorthogonal chemistry. Click chemistry revolutionized the options available to chemists for creating the molecules they desired. Bioorthogonal chemistry made it possible to monitor the chemical processes going on inside living cells without harming them.
Partnership combines miRecule’s unique RNA therapeutic discovery and conjugation platforms with Sanofi’s NANOBODY® technology to create a groundbreaking treatment for FSHD miRecule will receive an upfront payment with potential future milestone payments of nearly $400 million, in addition to tiered royalties Collaboration marks the first licensing transaction leveraging miRecule’s proprietary DREAmiR™ discovery platform, validating foundational science, and bolstering commitment to further expansion of the company’s RNA therapeutic pipeline October 04, 2022 07:00 AM Eastern Daylight Time GAITHERSBURG, Md.--(BUSINESS WIRE)--miRecule, Inc., an innovator of next-generation RNA therapeutics, today announced a strategic collaboration and exclusive license agreement with Sanofi to develop and commercialize a best-in-class antibody-RNA conjugate (ARC) for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The collaboration marks miRecule’s first licensing transaction leveraging its proprietary DREAmiR platform.
The region’s first program focused on climate-centered startups is officially launching.
Last year, engineers at Purdue University used their expertise in materials science to produce the world’s whitest paint, with an ability to reflect around 98% of incoming sunlight and therefore holds great potential when it comes to energy efficiency for buildings. The team has now made some tweaks to the recipe and produced a version that is thinner and lighter, which they say is ideal for use on cars, trains and planes.
While Winston Churchill was famously supposed to have remarked that we should never waste a crisis, the reality is that during recessions, firms often tighten their belts and reduce the amount they invest in innovation.
Scientists may never find the elixir of life, but they are finding new ways to extend our life spans. One day, protecting our cells from aging may be as easy as taking a pill. Mayo Clinic researchers say senolytic drugs can boost a key protein in the body that may protect older people against aspects of aging and a range of diseases. Their findings, which are published in eBioMedicine demonstrate this in mice and human studies.
Now might be the time to get solar panels on your roof. After the Inflation Reduction Act boosted the solar investment tax credit to 30 percent, going solar may be easier for some. On the other hand, recent inflation might make it harder. Either way, you'll want to make sure you do your homework before buying solar panels for your rooftop.
Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries.
When it comes to developing treatments and eventual cures for diseases, being able to diagnose a condition early and accurately makes a huge difference – and scientists have now developed a quick, reliable method of identifying people with Parkinson's disease.
The Great Pacific Garbage Patch is an enormous agglomeration of plastic waste floating in the world's largest ocean, but it's not the only one and now scientists are trying to work out how to clean them up. R Reach Penaflor is a man with a mission. Since 2009, he has been working closely with the River Warriors, a group bent on cleaning up estuaries feeding into the Pasig River, which runs through the Philippines' largest urban area, Metro Manila, and is notorious for its noxious smells. Scientists describe the Pasig as the river most responsible for polluting the marine environment.
Microplastics contaminate the whole planet, from Arctic ice to Mount Everest. The tiny particles, less than 5 millimeters in diameter, are in the air we breathe, and have been found in human placenta, blood and lungs.
Cancer’s ability to spread through the body is one of its most devastating tricks. Scientists at Cambridge have now identified a protein that plays a key role in metastasis, which not only hints at a new potential treatment but reveals for the first time that this process isn’t unique to cancer.
Scientists have managed to turn one of the deadliest insects into a vaccine delivery system. According to new reports from NPR, a clinical trial for a system meant to use mosquitoes to deliver vaccines has been underway in the United Kingdom. The findings of the trial have been published in Science Translational Medicine.
Engineers at MIT and the National Renewable Energy Laboratory (NREL) have designed a heat engine with no moving parts. Their new demonstrations show that it converts heat to electricity with over 40 percent efficiency — a performance better than that of traditional steam turbines.
You’ve never seen Jupiter like this.
If a single medical objective could be applied to the entire range of cancers, it would be detecting the disease as soon as possible. “At the highest level, finding any cancer early gives you the opportunity for curative treatments,” says Andrea Ferris, CEO of research funding organization, LUNGevity. Although the goal of early detection emerged decades ago, much work remains to be done. Low-dose computed tomography (CT) scanning, used to detect lung cancer, has not changed much in the past ten years, and Ferris says that another part of the problem is a lack of public awareness of the “importance of screening and that it can save lives.”